NCT01556607View on ClinicalTrials.gov

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Drug Safety
Interventions
DRUG

MDT-637

Inhaled doses of MDT-637 over a 24 hour period at 3 visits

DRUG

Placebo

Trial Locations (1)

92626

West Coast Clinical Trials, Costa Mesa

Sponsors
All Listed Sponsors
lead

MicroDose Therapeutx, Inc

INDUSTRY